Metabolomics-focused life sciences company Metabolon and genomic medicine organization Genomics England announced they will partner to advance the characterization of hundreds of rare diseases with the goal of advancing rare disease diagnosis. Metabolon will generate metabolomic data for more than 7,000 participants of the 100,000 Genome Project, one of the first government-funded population-based genomics projects […]
